492 related articles for article (PubMed ID: 16049350)
41. Interaction between the antigen and antibody is controlled by the constant domains: normal mode dynamics of the HEL-HyHEL-10 complex.
Adachi M; Kurihara Y; Nojima H; Takeda-Shitaka M; Kamiya K; Umeyama H
Protein Sci; 2003 Oct; 12(10):2125-31. PubMed ID: 14500870
[TBL] [Abstract][Full Text] [Related]
42. Incorporating receptor flexibility in the molecular design of protein interfaces.
Li L; Liang S; Pilcher MM; Meroueh SO
Protein Eng Des Sel; 2009 Sep; 22(9):575-86. PubMed ID: 19643976
[TBL] [Abstract][Full Text] [Related]
43. Crystal structure of the anti-(carcinoembryonic antigen) single-chain Fv antibody MFE-23 and a model for antigen binding based on intermolecular contacts.
Boehm MK; Corper AL; Wan T; Sohi MK; Sutton BJ; Thornton JD; Keep PA; Chester KA; Begent RH; Perkins SJ
Biochem J; 2000 Mar; 346 Pt 2(Pt 2):519-28. PubMed ID: 10677374
[TBL] [Abstract][Full Text] [Related]
44. Unusual joining sites in the H and L chains of an anti-lysozyme antibody.
Hartman AB; Mallett CP; Sheriff S; Smith-Gill SJ
J Immunol; 1988 Aug; 141(3):932-6. PubMed ID: 3135317
[TBL] [Abstract][Full Text] [Related]
45. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.
Lee CV; Liang WC; Dennis MS; Eigenbrot C; Sidhu SS; Fuh G
J Mol Biol; 2004 Jul; 340(5):1073-93. PubMed ID: 15236968
[TBL] [Abstract][Full Text] [Related]
46. Substantial energetic improvement with minimal structural perturbation in a high affinity mutant antibody.
Midelfort KS; Hernandez HH; Lippow SM; Tidor B; Drennan CL; Wittrup KD
J Mol Biol; 2004 Oct; 343(3):685-701. PubMed ID: 15465055
[TBL] [Abstract][Full Text] [Related]
47. Protein-protein recognition and interaction hot spots in an antigen-antibody complex: free energy decomposition identifies "efficient amino acids".
Lafont V; Schaefer M; Stote RH; Altschuh D; Dejaegere A
Proteins; 2007 May; 67(2):418-34. PubMed ID: 17256770
[TBL] [Abstract][Full Text] [Related]
48. Evidence for structural plasticity of heavy chain complementarity-determining region 3 in antibody-ssDNA recognition.
Schuermann JP; Prewitt SP; Davies C; Deutscher SL; Tanner JJ
J Mol Biol; 2005 Apr; 347(5):965-78. PubMed ID: 15784256
[TBL] [Abstract][Full Text] [Related]
49. Molecular characterization of a conformational epitope of hen egg white lysozyme by differential chemical modification of immune complexes and mass spectrometric peptide mapping.
Fiedler W; Borchers C; Macht M; Deininger SO; Przybylski M
Bioconjug Chem; 1998; 9(2):236-41. PubMed ID: 9548539
[TBL] [Abstract][Full Text] [Related]
50. Initial repertoire of anti-(4-hydroxy-3-nitrophenylacetyl) antibodies as potential donors for effective affinity maturation.
Furukawa K; Manabe A; Furukawa A; Kuba H; Okajima T; Azuma T
Mol Immunol; 2006 Apr; 43(11):1751-60. PubMed ID: 16406527
[TBL] [Abstract][Full Text] [Related]
51. The third-dimensional structure of the complex between an Fv antibody fragment and an analogue of the main immunogenic region of the acetylcholine receptor: a combined two-dimensional NMR, homology, and molecular modeling approach.
Kleinjung J; Petit MC; Orlewski P; Mamalaki A; Tzartos SJ; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Marraud M; Cung MT
Biopolymers; 2000 Feb; 53(2):113-28. PubMed ID: 10679615
[TBL] [Abstract][Full Text] [Related]
52. Epitope mapping of anti-interleukin-13 neutralizing antibody CNTO607.
Teplyakov A; Obmolova G; Wu SJ; Luo J; Kang J; O'Neil K; Gilliland GL
J Mol Biol; 2009 May; 389(1):115-23. PubMed ID: 19361524
[TBL] [Abstract][Full Text] [Related]
53. Enhanced conformational diversity search of CDR-H3 in antibodies: role of the first CDR-H3 residue.
Kim ST; Shirai H; Nakajima N; Higo J; Nakamura H
Proteins; 1999 Dec; 37(4):683-96. PubMed ID: 10651282
[TBL] [Abstract][Full Text] [Related]
54. Modeling protein-small molecule interactions: structure and thermodynamics of noble gases binding in a cavity in mutant phage T4 lysozyme L99A.
Mann G; Hermans J
J Mol Biol; 2000 Sep; 302(4):979-89. PubMed ID: 10993736
[TBL] [Abstract][Full Text] [Related]
55. Collagen type II is recognized by a pathogenic antibody through germline encoded structures.
Böiers U; Lanig H; Sehnert B; Holmdahl R; Burkhardt H
Eur J Immunol; 2008 Oct; 38(10):2784-95. PubMed ID: 18825755
[TBL] [Abstract][Full Text] [Related]
56. Conservation of water molecules in an antibody-antigen interaction.
Braden BC; Fields BA; Poljak RJ
J Mol Recognit; 1995; 8(5):317-25. PubMed ID: 8619952
[TBL] [Abstract][Full Text] [Related]
57. Solution structure and backbone dynamics of an antigen-free heavy chain variable domain (VHH) from Llama.
Renisio JG; Pérez J; Czisch M; Guenneugues M; Bornet O; Frenken L; Cambillau C; Darbon H
Proteins; 2002 Jun; 47(4):546-55. PubMed ID: 12001233
[TBL] [Abstract][Full Text] [Related]
58. Replacing the complementarity-determining regions in a human antibody with those from a mouse.
Jones PT; Dear PH; Foote J; Neuberger MS; Winter G
Nature; 1986 May 29-Jun 4; 321(6069):522-5. PubMed ID: 3713831
[TBL] [Abstract][Full Text] [Related]
59. Exploring the energy landscape of antibody-antigen complexes: protein dynamics, flexibility, and molecular recognition.
Thielges MC; Zimmermann J; Yu W; Oda M; Romesberg FE
Biochemistry; 2008 Jul; 47(27):7237-47. PubMed ID: 18549243
[TBL] [Abstract][Full Text] [Related]
60. An anti-urokinase plasminogen activator receptor (uPAR) antibody: crystal structure and binding epitope.
Li Y; Parry G; Chen L; Callahan JA; Shaw DE; Meehan EJ; Mazar AP; Huang M
J Mol Biol; 2007 Jan; 365(4):1117-29. PubMed ID: 17101149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
